Proclaim™ DRG Neurostimulator System for the management of chronic, intractable pain

Jonathan M. Hagedorn; Pavli S. Demian; Keith Austin Scarfo; Alyson M. Engle; Timothy R. Deer

doi:10.2217/pmt-2020-0010

Proclaim™ DRG Neurostimulator System for the management of chronic, intractable pain

Jonathan M. Hagedorn, Pavli S. Demian, Keith Austin Scarfo, Alyson M. Engle, Timothy R. Deer^*

^*Corresponding author for this work

Anesthesiology

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Chronic pain is consistently listed as one of the most costly and disabling health problems worldwide. In an effort to treat these suffering individuals, significant amounts of time and energy have been devoted to discover safe and effective pain relieving treatments. Dorsal root ganglion stimulation is the newest treatment modality to be created for chronic intractable pain. In this manuscript, we review the history and development, published research and safety profile of the Proclaim™ DRG Neurostimulator System (Abbott, TX, USA). At last, we offer our outlook on future developments with dorsal root ganglion stimulation.

Original language	English (US)
Pages (from-to)	225-233
Number of pages	9
Journal	Pain management
Volume	10
Issue number	4
DOIs	https://doi.org/10.2217/pmt-2020-0010
State	Published - Jul 2020

Keywords

DRG
chronic pain
dorsal root ganglion
neurostimulation

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.2217/pmt-2020-0010

Cite this

@article{c3a7a05104444274a278175f48f4195f,

title = "Proclaim{\texttrademark} DRG Neurostimulator System for the management of chronic, intractable pain",

abstract = "Chronic pain is consistently listed as one of the most costly and disabling health problems worldwide. In an effort to treat these suffering individuals, significant amounts of time and energy have been devoted to discover safe and effective pain relieving treatments. Dorsal root ganglion stimulation is the newest treatment modality to be created for chronic intractable pain. In this manuscript, we review the history and development, published research and safety profile of the Proclaim{\texttrademark} DRG Neurostimulator System (Abbott, TX, USA). At last, we offer our outlook on future developments with dorsal root ganglion stimulation.",

keywords = "DRG, chronic pain, dorsal root ganglion, neurostimulation",

author = "Hagedorn, {Jonathan M.} and Demian, {Pavli S.} and Scarfo, {Keith Austin} and Engle, {Alyson M.} and Deer, {Timothy R.}",

note = "Publisher Copyright: {\textcopyright} 2020 Future Medicine Ltd.",

year = "2020",

month = jul,

doi = "10.2217/pmt-2020-0010",

language = "English (US)",

volume = "10",

pages = "225--233",

journal = "Pain management",

issn = "1758-1869",

publisher = "CORE Medical Journals",

number = "4",

}

TY - JOUR

T1 - Proclaim™ DRG Neurostimulator System for the management of chronic, intractable pain

AU - Hagedorn, Jonathan M.

AU - Demian, Pavli S.

AU - Scarfo, Keith Austin

AU - Engle, Alyson M.

AU - Deer, Timothy R.

PY - 2020/7

Y1 - 2020/7

N2 - Chronic pain is consistently listed as one of the most costly and disabling health problems worldwide. In an effort to treat these suffering individuals, significant amounts of time and energy have been devoted to discover safe and effective pain relieving treatments. Dorsal root ganglion stimulation is the newest treatment modality to be created for chronic intractable pain. In this manuscript, we review the history and development, published research and safety profile of the Proclaim™ DRG Neurostimulator System (Abbott, TX, USA). At last, we offer our outlook on future developments with dorsal root ganglion stimulation.

AB - Chronic pain is consistently listed as one of the most costly and disabling health problems worldwide. In an effort to treat these suffering individuals, significant amounts of time and energy have been devoted to discover safe and effective pain relieving treatments. Dorsal root ganglion stimulation is the newest treatment modality to be created for chronic intractable pain. In this manuscript, we review the history and development, published research and safety profile of the Proclaim™ DRG Neurostimulator System (Abbott, TX, USA). At last, we offer our outlook on future developments with dorsal root ganglion stimulation.

KW - DRG

KW - chronic pain

KW - dorsal root ganglion

KW - neurostimulation

UR - http://www.scopus.com/inward/record.url?scp=85097840654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097840654&partnerID=8YFLogxK

U2 - 10.2217/pmt-2020-0010

DO - 10.2217/pmt-2020-0010

M3 - Article

C2 - 32423306

AN - SCOPUS:85097840654

SN - 1758-1869

VL - 10

SP - 225

EP - 233

JO - Pain management

JF - Pain management

IS - 4

ER -

Proclaim™ DRG Neurostimulator System for the management of chronic, intractable pain

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this